Risankizumab (Skyrizi)
See a licensed clinician online about Risankizumab (Skyrizi), or refill a current prescription.
Skyrizi (risankizumab) is a prescription biologic for moderate-to-severe plaque psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis in adults. Crohn's and ulcerative colitis use intravenous induction dosing followed by higher-dose subcutaneous maintenance — not the 150 mg pen.
Ondoc treats psoriasis, psoriatic arthritis, Crohn's disease, ulcerative colitis and related conditions
- Insurance accepted
- Self-pay $50
- One-time visit, no subscription required
Prescription and treatment depend on clinician evaluation and medical appropriateness.
If your prescription ran out and you need Risankizumab (Skyrizi) refilled, start a Risankizumab (Skyrizi) refill.
Available strengths and common directions
- Risankizumab (Skyrizi) 150 mg/mL pen (plaque psoriasis / psoriatic arthritis)Inject 150 mg under the skin as directed by your clinician · Qty 1